• Improved factor VIII preparations have made major surgery feasible for hemophiliac patients, as well as increasing their survival. In a hemophiliac undergoing prostatectomy, the effects of local or systemic fibrinolysis and possible disseminated intravascular coagulation must be considered, in addition to the factor VIII deficiency. We successfully treated an octogenarian with benign prostatic hypertrophy and mild hemophilia during and after suprapubic prostatectomy by infusions of antihemophilic factor (factor VIII) concentrate. Cessation of infusion on the 15th day resulted in bleeding two days later. This ceased after resumption of antihemophilic factor infusion. Tests for abnormal fibrinolysis and fibrin split products gave negative results.
(Arch Surg 111:818-821, 1976)
Wylin R, Schneider J. Prostatectomy in an 85-Year-Old Hemophiliac. Arch Surg. 1976;111(7):818–821. doi:10.1001/archsurg.1976.01360250094020
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: